I-Doxorubicin Hydrochloride Liposome Injection

Ulwazi Lomkhiqizo

Igama:I-Doxorubicin Hydrochloride Liposome Injection

Igama langaphandle:I-Caelyx

Imvelo:Ukulungiswa kwe-Liposome

Ukuhlukaniswa kwezidakamizwa:Isigaba se-anti-tumor antibiotic

Izithako:I-Doxorubicin Hydrochloride Liposome

Isici

I-Doxorubicin hydrochloride ivalwe kuma-liposomes ngokubopha phezulu ku-methoxy polyethylene glycol.Le nqubo, eyaziwa ngokuthi ukuzinza kwendawo noma i-cryptography, ivikela ama-liposomes ekubonweni yi-mononuclear macrophage system (MPS) futhi ngaleyo ndlela andise isikhathi sawo sokujikeleza.

Lo mkhiqizo ukumiswa okubomvu okubulalayo, okucwebezelayo okuqukethe u-2 mg/mL we-doxorubicin hydrochloride ngevial ​​engu-10 mL, futhi ugxile ekuphathweni komthamo owodwa emthanjeni.Isithako esisebenzayo yi-doxorubicin hydrochloride, isibulala-magciwane se-anthracycline cytotoxic esithathwe kusiko le-Streptomyces bosei epi-gris variant.

Izinkomba

Ingasetshenziswa ezigulini ezine-Kaposi's sarcoma (AIDS-KS) ehlobene ne-AIDS (AIDS-KS) ene-CD4 ephansi kanye nesifo esibanzi se-cutaneous mucosal visceral.

Izinkonzo Zethu

1.Imikhiqizo:Nikeza izingcaphuno zezitshalo ezisezingeni eliphezulu, ezihlanzeke kakhulu, izinto zokusetshenziswa zemithi, izimaphakathi zemithi, kanye namalungiselelo akhethekile emithi.

2.Izinsizakalo zobuchwepheshe:Izingcaphuno ezenziwe ngokwezifiso ezinemininingwane ekhethekile ngokuya ngezidingo zekhasimende.

I-Hande Factory

I-Yunnan hande Biotechnology Co., Ltd., eyasungulwa ngo-Agasti 1993, iyibhizinisi lobuchwepheshe obuphezulu eligxile ocwaningweni nasekuthuthukisweni kwe-biotechnology.Ngemva kweminyaka yokuthuthuka, i-hande isungule uhlelo oluphelele lwekhwalithi, ilawula ikhwalithi yemikhiqizo ngokuvumelana namazinga aphezulu, futhi yandisa inani lokukhipha amandla okukhiqiza.Imikhiqizo yayo isiphasise isitifiketi semithetho neziqondiso zamazwe ngamazwe, futhi ibe umkhiqizi wezitshalo ezingavuthiwe okwenza wonke umuntu azizwe ekhululekile.